Network approaches to systems biology analysis of complex disease: Integrative methods for multi-omics data

Briefings in Bioinformatics

Volumn 19, Issue 6, 2017, Pages 1370-1381

  Yan, Jingwen ^a   Risacher, Shannon L ^c   Shen, Li ^b   Saykin, Andrew J ^b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

Computational methods; Integrative omics; Network approaches; Systems biology

Indexed keywords

TRANSCRIPTOME;

DATA MINING; EPISTASIS; GENOMICS; MACHINE LEARNING; PROTEOMICS; SYSTEMS BIOLOGY;

DATA MINING; EPISTASIS, GENETIC; GENOMICS; MACHINE LEARNING; PROTEOMICS; SYSTEMS BIOLOGY; TRANSCRIPTOME;

EID: 85057257442     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbx066     Document Type: Article

References (110)

1. Shen L, Kim S, Risacher SL, et al. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: a study of the ADNI cohort. Neuroimage 2010;53(3):1051-63.
2. Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013;45(12):1452-8.
3. Simon-Sanchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009;41(12):1308-12.
4. Zhang B, Gaiteri C, Bodea LG, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 2013;153(3):707-20.
5. Pottier C, Ravenscroft TA, Brown PH, et al. TYROBP genetic variants in early-onset Alzheimer's disease. Neurobiol Aging 2016;48:222.e9-e15.
6. Civelek M, Lusis AJ. Systems genetics approaches to understand complex traits. Nat Rev Genet 2014;15(1):34-48.
7. Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature 2009;461(7261):218-23.
8. Weiner MW, Aisen PS, Jack CR, Jr et al. The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement 2010;6(3):202.e7-11.e7.
9. Saykin AJ, Shen L, Yao X, et al. Genetic studies of quantitative MCI and AD phenotypes in ADNI: progress, opportunities, and plans. Alzheimers Dement 2015;11(7):792-814.
10. Brubaker D, Difeo Chen AY, et al. Drug Intervention Response Predictions with PARADIGM (DIRPP) identifies drug resistant cancer cell lines and pathway mechanisms of resistance. Pac Symp Biocomput 2014:125-35.
11. The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014;507(7492):315-22.
12. The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011;474(7353):609-15.
13. Ciriello G, Gatza ML, Beck AH, et al. Comprehensive molecular portraits of invasive lobular breast cancer. Cell 2015;163(2):506-19.
14. Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69(1):138-47.
15. Moore JH, Williams SM. Epistasis and its implications for personal genetics. Am J Hum Genet 2009;85(3):309-20.
16. Yan J, Kim S, Nho SK, et al. Hippocampal transcriptome-guided genetic analysis of correlated episodic memory phenotypes in Alzheimer's disease. Front Genet 2015;6:117.
17. Tyler AL, McGarr TC, Beyer BJ, et al. A genetic interaction network model of a complex neurological disease. Genes Brain Behav 2014;13(8):831-40.
18. Hemani G, Knott S, Haley C. An evolutionary perspective on epistasis and the missing heritability. PLoS Genet 2013;9(2):e1003295.
19. Sackton TB, Hartl DL. Genotypic context and epistasis in individuals and populations. Cell 2016;166(2):279-87.
20. Kryazhimskiy S, Rice DP, Jerison ER, et al. Microbial evolution. global epistasis makes adaptation predictable despite sequence-level stochasticity. Science 2014;344(6191):1519-22.
21. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81(3):559-75.
22. Herold C, Steffens M, Brockschmidt FF, et al. INTERSNP: genome-wide interaction analysis guided by a priori information. Bioinformatics 2009;25(24):3275-81.
23. Cordell HJ. Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet 2009;10(6):392-404.
24. Schupbach T, Xenarios I, Bergmann S, et al. FastEpistasis: a high performance computing solution for quantitative trait epistasis. Bioinformatics 2010;26(11):1468-9.
25. Wan X, Yang C, Yang Q, et al. BOOST: a fast approach to detecting gene-gene interactions in genome-wide case-control studies. Am J Hum Genet 2010;87(3):325-40.
26. Yang C, He Z, Wan X, et al. SNPHarvester: a filtering-based approach for detecting epistatic interactions in genomewide association studies. Bioinformatics 2009;25(4):504-11.
27. Liu Y, Xu H, Chen S, et al. Genome-wide interaction-based association analysis identified multiple new susceptibility Loci for common diseases. PLoS Genet 2011;7(3):e1001338.
28. Hemani G, Theocharidis A, Wei W, et al. EpiGPU: exhaustive pairwise epistasis scans parallelized on consumer level graphics cards. Bioinformatics 2011;27(11):1462-5.
29. Grady BJ, Torstenson E, Dudek SM, et al. Finding unique filter sets in PLATO: a precursor to efficient interaction analysis in GWAS data. Pac Symp Biocomput 2010:315-26.
30. Zhao JY, Jin L, Xiong MM. Test for interaction between two unlinked loci. Am J Hum Genet 2006;79(5):831-45.
31. Kam-Thong T, Czamara D, Tsuda K, et al. EPIBLASTER-fast exhaustive two-locus epistasis detection strategy using graphical processing units. Eur J Hum Genet 2011;19(4):465-71.
32. Prabhu S, Pe'er I. Ultrafast genome-wide scan for SNP-SNP interactions in common complex disease. Genome Res 2012;22(11):2230-40.
33. Arkin Y, Rahmani E, Kleber ME, et al. EPIQ-efficient detection of SNP-SNP epistatic interactions for quantitative traits. Bioinformatics 2014;30(12):i19-i25.
34. Motsinger AA, Ritchie MD. Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene-gene interactions in human genetics and pharmaco-genomics studies. Hum Genomics 2006;2(5):318-28.
35. Lee SY, Chung Y, Elston RC, et al. Log-linear model-based multifactor dimensionality reduction method to detect gene gene interactions. Bioinformatics 2007;23(19):2589-95.
36. Greene CS, Penrod NM, Kiralis J, et al. Spatially uniform reliefF (SURF) for computationally-efficient filtering of gene-gene interactions. BioData Min 2009;2(1):5.
37. Bush WS, Dudek SM, Ritchie MD. Parallel multifactor dimensionality reduction: a tool for the large-scale analysis of gene-gene interactions. Bioinformatics 2006;22(17):2173-4.
38. Zhang Y, Liu JS. Bayesian inference of epistatic interactions in case-control studies. Nat Genet 2007;39(9):1167-73.
39. Moore JH, Gilbert JC, Tsai CT, et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 2006;241(2):252-61.
40. Chanda P, Zhang A, Brazeau D, et al. Information-theoretic metrics for visualizing gene-environment interactions. Am J Hum Genet 2007;81(5):939-63.
41. Wei WH, Hemani G, Haley CS. Detecting epistasis in human complex traits. Nat Rev Genet 2014;15(11):722-33.
42. Upton A, Trelles O, Cornejo-Garcia JA, et al. Review: high-performance computing to detect epistasis in genome scale data sets. Brief Bioinform 2016;17(3):368-79.
43. Koo CL, Liew MJ, Mohamad MS, et al. A review for detecting gene-gene interactions using machine learning methods in genetic epidemiology. Biomed Res Int 2013;2013:432375.
44. Hemani G, Shakhbazov K, Westra HJ, et al. Detection and replication of epistasis influencing transcription in humans. Nature 2014;508(7495):249-53.
45. Chiesa A, Lia L, Han C, et al. Investigation of epistasis between DAOA and 5HTR1A variants on clinical outcomes in patients with Schizophrenia. Genet Test Mol Biomarkers 2013;17(6):504-7.
46. Upton A, Trelles O, Perkins J. Epistatic analysis of Clarkson disease. Procedia Comput Sci 2015;51:725-34.
47. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008;9:559.
48. Faith JJ, Hayete B, Thaden JT, et al. Large-scale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles. PLoS Biol 2007;5(1):54-66.
49. Margolin AA, Nemenman I, Basso K, et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 2006;7:S7.
50. Meyer PE, Lafitte F, Bontempi G. minet: A R/Bioconductor package for inferring large transcriptional networks using mutual information. BMC Bioinformatics 2008;9:461.
51. Haury AC, Mordelet Vera-Licona FP, et al. TIGRESS: Trustful Inference of Gene REgulation using Stability Selection. BMC Syst Biol 2012;6:145.
52. Huynh-Thu VA, Irrthum A, Wehenkel L, et al. Inferring regulatory networks from expression data using tree-based methods. PLoS One 2010;5(9):e12776.
53. Petralia F, Wang P, Yang JL, et al. Integrative random forest for gene regulatory network inference. Bioinformatics 2015;31(12):197-205.
54. Friedman N, Linial M, Nachman I, et al. Using Bayesian networks to analyze expression data. J Comput Biol 2000;7(3-4):601-20.
55. Wilczynski B, Dojer N. BNFinder: exact and efficient method for learning Bayesian networks. Bioinformatics 2009;25(2):286-7.
56. Jennen DG, van Leeuwen DM, Hendrickx DM, et al. Bayesian network inference enables unbiased phenotypic anchoring of transcriptomic responses to cigarette smoke in humans. Chem Res Toxicol 2015;28(10):1936-48.
57. Yu J, Smith VA, Wang PP, et al. Advances to Bayesian network inference for generating causal networks from observational biological data. Bioinformatics 2004;20(18):3594-603.
58. Taylor RC, Shah A, Treatman C, et al. SEBINI: Software Environment for BIological Network Inference. Bioinformatics 2006;22(21):2706-8.
59. Zoppoli P, Morganella S, Ceccarelli M. TimeDelay-ARACNE: reverse engineering of gene networks from time-course data by an information theoretic approach. BMC Bioinformatics 2010;11:154.
60. Villaverde AF, Ross J, Moran F, et al. MIDER: network inference with mutual information distance and entropy reduction. PLoS One 2014;9(5):e96732.
61. Marbach D, Costello JC, Kuffner R, et al. Wisdom of crowds for robust gene network inference. Nat Methods 2012;9(8):796-804.
62. De Smet R, Marchal K. Advantages and limitations of current network inference methods. Nat Rev Microbiol 2010;8(10):717-29.
63. Hurley DG, Cursons J, Wang YK, et al. NAIL, a software tool-set for inferring, analyzing and visualizing regulatory networks. Bioinformatics 2015;31(2):277-8.
64. Peterson C, Vannucci M, Karakas C, et al. Inferring metabolic networks using the Bayesian adaptive graphical lasso with informative priors. Stat Interface 2013;6(4):547-58.
65. Aubry S, Shin W, Crary JF, et al. Assembly and interrogation of Alzheimer's disease genetic networks reveal novel regulators of progression. PLoS One 2015;10(3):e0120352.
66. Rembach A, Stingo FC, Peterson C, et al. Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's disease. J Alzheimers Dis 2015;44(3):917-25.
67. Ramanan VK, Shen L, Moore JH, et al. Pathway analysis of genomic data: concepts, methods, and prospects for future development. Trends Genet 2012;28(7):323-32.
68. Wang J, Duncan D, Shi Z, et al. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res 2013;41:W77-83.
69. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009;37(1):1-13.
70. Glaab E, Baudot A, Krasnogor N, et al. EnrichNet: network-based gene set enrichment analysis. Bioinformatics 2012;28(18):i451-7.
71. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34(3):267-73.
72. Wang K, Li MY, Bucan M. Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 2007;81(6):1278-83.
73. Tintle NL, Borchers B, Brown M, et al. Comparing gene set analysis methods on single-nucleotide polymorphism data from genetic analysis workshop 16. BMC Proc 2009;3(Suppl 7):S96.
74. Baryshnikova A. Systematic functional annotation and visualization of biological networks. Cell Syst 2016;2(6):412-21.
75. Tarca AL, Draghici S, Khatri P, et al. A novel signaling pathway impact analysis. Bioinformatics 2009;25(1):75-82.
76. Ben-Hamo R, Gidoni M, Efroni S. PhenoNet: identification of key networks associated with disease phenotype. Bioinformatics 2014;30(17):2399-405.
77. Szklarczyk D, Franceschini A, Kuhn M, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011;39:D561-8.
78. Chatr-Aryamontri A, Breitkreutz BJ, Oughtred R, et al. The BioGRID interaction database: 2015 update. Nucleic Acids Res 2015;43:D470-8.
79. Keshava Prasad TS, Goel R, Kandasamy K, et al. Human protein reference database-2009 update. Nucleic Acids Res 2009;37:D767-72.
80. Ma J, Shojaie A, Michailidis G. Network-based pathway enrichment analysis with incomplete network information. Bioinformatics 2016;32(20):3165-74.
81. Berry MP, Graham CM, McNab FW, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010;466(7309):973-7.
82. Baranzini SE, Srinivasan R, Khankhanian P, et al. Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain 2010;133(9):2603-11.
83. Leiserson MD, Vandin F, Wu HT, et al. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat Genet 2015;47(2):106-14.
84. Jia P, Zheng S, Long J, et al. dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks. Bioinformatics 2011;27(1):95-102.
85. Akula N, Baranova A, Seto D, et al. A network-based approach to prioritize results from genome-wide association studies. PLoS One 2011;6(9):e24220.
86. Oti M, Snel B, Huynen MA, et al. Predicting disease genes using protein-protein interactions. J Med Genet 2006;43(8):691-8.
87. Franke L, van Bakel H, Fokkens L, et al. Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. Am J Hum Genet 2006;78(6):1011-25.
88. Kohler S, Bauer S, Horn D, et al. Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet 2008;82(4):949-58.
89. Greene CS, Krishnan A, Wong AK, et al. Understanding multicellular function and disease with human tissue-specific networks. Nat Genet 2015;47(6):569-76.
90. Pyatnitskiy M, Mazo I, Shkrob M, et al. Clustering gene expression regulators: new approach to disease subtyping. PLoS One 2014;9(1):e84955.
91. Drier Y, Sheffer M, Domany E. Pathway-based personalized analysis of cancer. Proc Natl Acad Sci USA 2013;110(16):6388-93.
92. Greenblum SI, Efroni S, Schaefer CF, et al. The PathOlogist: an automated tool for pathway-centric analysis. BMC Bioinformatics 2011;12:133.
93. Glaab E. Using prior knowledge from cellular pathways and molecular networks for diagnostic specimen classification. Brief Bioinform 2015;17(3):440-52.
94. Yan J, Du L, Kim S, et al. Transcriptome-guided amyloid imaging genetic analysis via a novel structured sparse learning algorithm. Bioinformatics 2014;30(17):i564-71.
95. Li CY, Li HZ. Network-constrained regularization and variable selection for analysis of genomic data. Bioinformatics 2008;24(9):1175-82.
96. Vaske CJ, Benz SC, Sanborn JZ, et al. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics 2010;26(12):i237-45.
97. Bonnet E, Calzone L, Michoel T. Integrative multi-omics module network inference with lemon-tree. PLoS Comput Biol 2015;11(2):e1003983.
98. Holzinger ER, Dudek SM, Frase AT, et al. ATHENA: the analysis tool for heritable and environmental network associations. Bioinformatics 2014;30(5):698-705.
99. Zhu J, Sova P, Xu QW, et al. Stitching together multiple data dimensions reveals interacting metabolomic and transcriptomic networks that modulate cell regulation. PLoS Biol 2012;10(4):e1001301.
100. Ramirez LM, Goukasian N, Porat S, et al. Common variants in ABCA7 and MS4A6A are associated with cortical and hippo-campal atrophy. Neurobiol Aging 2016;39:82-9.
101. Prasad V. Perspective: the precision-oncology illusion. Nature 2016;537(7619):S63.
102. Abrahams E, Eck SL. Molecular medicine: precision oncology is not an illusion. Nature 2016;539(7629):357.
103. The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature 2017;543(7645):378-84.
104. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012;489(7417):519-25.
105. Whitaker JW, Boyle DL, Bartok B, et al. Integrative omics analysis of rheumatoid arthritis identifies non-obvious therapeutic targets. PLoS One 2015;10(4):e0124254.
106. Zhang JG, Tan LJ, Xu C, et al. Integrative analysis of transcriptomic and epigenomic data to reveal regulation patterns for BMD variation. PLoS One 2015;10(9):e0138524.
107. Shin SY, Fauman EB, Petersen AK, et al. An atlas of genetic influences on human blood metabolites. Nat Genet 2014;46(6):543-50.
108. Bartel J, Krumsiek J, Schramm K, et al. The human blood metabolome-transcriptome interface. PLoS Genet 2015;11(6):e1005274.
109. Kim D, Li R, Dudek SM, et al. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer. J Biomed Inform 2015;56:220-8.
110. Ritchie MD, Holzinger ER, Li R, et al. Methods of integrating data to uncover genotype-phenotype interactions. Nat Rev Genet 2015;16(2):85-97.